Coocon records 27.9% operating margin in Q1 2026, enhances shareholder value through share cancellation and new business expansion

Q1 2026 consolidated revenue KRW 16.0bn (down 7.5% YoY), operating profit KRW 4.5bn (margin 27.9%), net income KRW 7.4bn
Operating margin improved YoY (24.5% → 27.9%) despite slight revenue decline
September 2025: Cancelled 162,953 treasury shares (~3.7% of total) without capital reduction
Dividend policy: Target shareholder return within 15% of operating profit, quarterly dividend introduced
Net debt ratio 13.24% (vs 14.25% year-end 2025), cash & equivalents KRW 131.9bn, total borrowings KRW 5.7bn
New business purposes added: medical mydata, global cross-border payments, direct debit electronic payment issuance
Holds data specialist license, offers 300+ APIs, partnerships with 2,000+ institutions
Key risk: Shareholder register inspection lawsuit (granted) but financial impact negligible
Credit rating BBB+ (stable), cash flow grade CF1(A)